Aton Pharma Inc. FDA Inspection Record
Aton Pharma Inc. is an FDA-inspected facility (FEI 3005740291) located in Lawrenceville, NJ, US. RegDataLab tracks 1 FDA inspection at this facility.
What FDA found at this site
- Latest inspection
- Sep 10, 2009: Voluntary Action Indicated (VAI)
- Inspections on record
- 1 (1 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 1, latest Feb 17, 2010
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 10, 2009 | Voluntary Action Indicated (VAI) | Failure to develop written procedures (21 CFR 314.80(b)) Failure by applicant to report ADE (21 CFR 314.80(c)) Late submission of annual safety reports (21 CFR 314.80(c)(2)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Feb 17, 2010 | Class II | D-373-2010 | Demser (Metyrosine) capsules, 250 mg; 100 capsules per bottle; Rx only; Distributed by… Failed USP Dissolution Test Requirements. Samples of Demser lot 9F661, Exp 5/2012 have failed to meet dissolution specifications. |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
2 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-373-2010, this FEI as the recalling firm | Feb 17, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 10, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Aton Pharma Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Aton Pharma Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Aton Pharma Inc.
- Location
- Lawrenceville, NJ (US)
- Source
- inspections